Pimco fund beating 97% of peers cuts Magnificent Seven to bet on Asia
Wall Street is growing sceptical over whether high valuations, soaring AI spending can justify further gains
Pimco’s flagship 60/40 Balanced Income and Growth Fund, overseen by Emmanuel Sharef, has been outperforming 97% of peers over the past three years. Sharef has recently shifted focus away from the Magnificent Seven, a group of US tech stocks, due to high valuations and concerns about their earnings outlook amid soaring AI spending.
Instead, the fund is betting on Asian equipment suppliers, Chinese financials, and healthcare stocks. Sharef expects this strategy to remain effective as long as profit growth remains strong, given the enormous capital expenditures required for AI data centers. The fund is also bullish on biotech and materials sectors, citing strong earnings growth and exposure to companies further down the AI supply chain.
Brief written by urgent.news from The Business Times - Companies & Markets's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
